CPIM
HALO icon

Columbia Partners Investment Management’s Halozyme HALO Stock Holding History

Columbia Partners Investment Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-391,890
Closed -$4.98M – 352
2014
Q1 		$4.98M Buy
+391,890
New +$5.82M 0.22% 148

Other funds holding HALO

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Columbia Partners Investment Management's HALO Position: Q2 2014 in Review

Columbia Partners Investment Management sold out of Halozyme (HALO) in Q2 2014, closing a stake of 391,890 shares — an estimated $4.98M sold.

Columbia Partners Investment Management first reported a position in HALO in Q1 2014 and held it in 1 quarter. The position peaked at $4.98M in Q1 2014. 128 funds tracked by Wall St. Rank hold HALO as of Q2 2014.

  • Columbia Partners Investment Management reported no remaining Halozyme position as of Q2 2014 after selling out during the quarter.
  • Columbia Partners Investment Management sold 391,890 Halozyme shares in Q2 2014, an estimated $4.98M.
  • Columbia Partners Investment Management first reported a position in Halozyme in Q1 2014 and held it in 1 quarter.
  • Columbia Partners Investment Management's Halozyme position peaked at $4.98M in Q1 2014.
  • 128 funds tracked by Wall St. Rank held Halozyme as of Q2 2014.

Based on Columbia Partners Investment Management's 13F filing for Q2 2014, filed 13 Aug 2014.